Breast cancer patients receiving Herceptin treatment should be monitored for heart da

[News]

Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored for heart damage regardless of age, according to a new multi-centre study in Ontario.

More... (http://www.medicalnewstoday.com/releases/309304.php)